You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 252 No. 7, August 17, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Toxoplasmic Encephalitis in Patients With Acquired Immune Deficiency Syndrome

Benjamin J. Luft, MD; Robert G. Brooks, MD; Frances K. Conley, MD; Robert E. McCabe, MD; Jack S. Remington, MD

JAMA. 1984;252(7):913-917.


Abstract

An epidemic of cases of toxoplasmic encephalitis is occurring in patients with acquired immune deficiency syndrome (AIDS). Serological or histopathologic studies were performed on 70 cases with AIDS and toxoplasmic encephalitis. In many cases conventional stains of brain-tissue specimens failed to disclose Toxoplasma organisms; all were positive when stained by the peroxidase-antiperoxidase technique. Except for a single patient, serological titers were not indicative of an acute acquired infection. The ratio of titers in the agglutination test to titers in the Sabin-Feldman dye test seemed to be more predictive of active toxoplasmic encephalitis in patients with AIDS than either test alone. Based on histological and serological data, an approach is presented for diagnosis and treatment of suspected toxoplasmic encephalitis in patients with AIDS.

(JAMA 1984;252:913-917)



Author Affiliations

From the Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation (Drs Luft, Brooks, McCabe, and Remington), the Section of Neurosurgery, Veterans Administration Medical Center (Dr Conley), Palo Alto, Calif; the Division of Infectious Diseases, Department of Medicine, Stanford University Medical Center (Drs Luft, Brooks, McCabe, and Remington), and the Department of Neurosurgery, Stanford School of Medicine (Dr Conley), Stanford, Calif.


Footnotes

Reprint requests to Research Institute, Palo Alto Medical Foundation, 860 Bryant St, Palo Alto, CA 94301 (Dr Remington).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Kinetics and Phenotype of Vaccine-Induced CD8+ T-Cell Responses to Toxoplasma gondii
Jordan et al.
Infect. Immun. 2009;77:3894-3901.
ABSTRACT | FULL TEXT  

Structural Characterization of the Bradyzoite Surface Antigen (BSR4) from Toxoplasma gondii, a Unique Addition to the Surface Antigen Glycoprotein 1-related Superfamily
Crawford et al.
J. Biol. Chem. 2009;284:9192-9198.
ABSTRACT | FULL TEXT  

Temporal and Spatial Distribution of Toxoplasma gondii Differentiation into Bradyzoites and Tissue Cyst Formation In Vivo
Di Cristina et al.
Infect. Immun. 2008;76:3491-3501.
ABSTRACT | FULL TEXT  

TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-{gamma} production
Goldszmid et al.
JEM 2007;204:2591-2602.
ABSTRACT | FULL TEXT  

Coinfection Modulates Inflammatory Responses and Clinical Outcome of Helicobacter felis and Toxoplasma gondii Infections
Stoicov et al.
J. Immunol. 2004;173:3329-3336.
ABSTRACT | FULL TEXT  

A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis
Mordue and Sibley
J. Leukoc. Biol. 2003;74:1015-1025.
ABSTRACT | FULL TEXT  

Acute Toxoplasmosis Leads to Lethal Overproduction of Th1 Cytokines
Mordue et al.
J. Immunol. 2001;167:4574-4584.
ABSTRACT | FULL TEXT  

Initial Characterization of CST1, a Toxoplasma gondii Cyst Wall Glycoprotein
Zhang et al.
Infect. Immun. 2001;69:501-507.
ABSTRACT | FULL TEXT  

Expression of Herpes Simplex Virus Thymidine Kinase in Toxoplasma gondii Attenuates Tachyzoite Virulence in Mice
Radke and White
Infect. Immun. 1999;67:5292-5297.
ABSTRACT | FULL TEXT  

Evaluation of Recombinant Dense Granule Antigen 7 (GRA7) of Toxoplasma gondii for Detection of Immunoglobulin G Antibodies and Analysis of a Major Antigenic Domain
Jacobs et al.
CVI 1999;6:24-29.
ABSTRACT | FULL TEXT  

Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection
Denkers and Gazzinelli
Clin. Microbiol. Rev. 1998;11:569-588.
ABSTRACT | FULL TEXT  

Partially Protective Vaccination Permits the Development of Latency in a Normally Virulent Strain of Toxoplasma gondii
Yap et al.
Infect. Immun. 1998;66:4382-4388.
ABSTRACT | FULL TEXT  

Expression of Toxoplasma gondii-Specific Heat Shock Protein 70 during In Vivo Conversion of Bradyzoites to Tachyzoites
Silva et al.
Infect. Immun. 1998;66:3959-3963.
ABSTRACT | FULL TEXT  

Toxoplasma gondii Triggers Granulocyte-Dependent Cytokine-Mediated Lethal Shock in D-Galactosamine-Sensitized Mice
Marshall and Denkers
Infect. Immun. 1998;66:1325-1333.
ABSTRACT | FULL TEXT  

Central Nervous System Toxoplasmosis in AIDS
Klein et al.
NEJM 1993;328:1352-1354.
FULL TEXT  

Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine
Dannemann et al.
ANN INTERN MED 1992;116:33-43.
ABSTRACT  

Gastrointestinal Infections in AIDS
Smith et al.
ANN INTERN MED 1992;116:63-77.
ABSTRACT  

The Evaluation of Patients With Human Immunodeficiency Virus--Related Disorders and Brain Mass Lesions
Cimino et al.
Arch Intern Med 1991;151:1381-1384.
ABSTRACT  

Brain Lesions in Patients With Acquired Immunodeficiency Syndrome
Bishburg et al.
Arch Intern Med 1989;149:941-943.
ABSTRACT  

Treatment of Toxoplasmic Encephalitis With Intravenous Clindamycin
Dannemann et al.
Arch Intern Med 1988;148:2477-2482.
ABSTRACT  

Toxoplasma Peritonitis in a Patient With Acquired Immunodeficiency Syndrome
Israelski et al.
Arch Intern Med 1988;148:1655-1657.
ABSTRACT  

Intrathecal Production of Antibodies Against Toxoplasma gondii in Patients with Toxoplasmic Encephalitis and the Acquired Immunodeficiency Syndrome (AIDS)
POTASMAN et al.
ANN INTERN MED 1988;108:49-51.
ABSTRACT  

Treatment of Patients With Acquired Immunodeficiency Syndrome and Associated Manifestations
Kaplan et al.
JAMA 1987;257:1367-1374.
ABSTRACT  

Coccidioidomycosis in the Acquired Immunodeficiency Syndrome
BRONNIMANN et al.
ANN INTERN MED 1987;106:372-379.
ABSTRACT  

The Clinical Challenges of AIDS and HIV Infection
Mayer
J Law Med Ethics 1986;14:281-289.
 

Failure of Spiramycin to Prevent Neurotoxoplasmosis in Immunosuppressed Patients
Leport et al.
JAMA 1986;255:2290-2290.
ABSTRACT  

Bacteremia and Fungemia in Patients with the Acquired Immunodeficiency Syndrome
WHIMBEY et al.
ANN INTERN MED 1986;104:511-514.
ABSTRACT  

Bacterial Pneumonia in Patients with the Acquired Immunodeficiency Syndrome
POLSKY et al.
ANN INTERN MED 1986;104:38-41.
ABSTRACT  

Treatment of Infections in Patients with the Acquired Immunodeficiency Syndrome
ARMSTRONG et al.
ANN INTERN MED 1985;103:738-743.
ABSTRACT  

Multiple Opportunistic Infections and Neoplasms in the Acquired Immunodeficiency Syndrome
Wormser
JAMA 1985;253:3441-3442.
ABSTRACT  

Tissue Culture Isolation of Toxoplasma From Blood of a Patient With AIDS
Hofflin and Remington
Arch Intern Med 1985;145:925-926.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.